• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients.

作者信息

Kumar Karan, Mishra Manjul

机构信息

BGS Global Hospitals Bangalore, Bangalore, India.

Gastro and Liver Care Centre, Prayagraj, India.

出版信息

Aliment Pharmacol Ther. 2020 Aug;52(3):575-576. doi: 10.1111/apt.15829.

DOI:10.1111/apt.15829
PMID:32656835
Abstract
摘要

相似文献

1
Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients.信函：仅中度水平的血清乙型肝炎病毒DNA与慢性乙型肝炎患者肝细胞癌风险增加无关。
Aliment Pharmacol Ther. 2020 Aug;52(3):575-576. doi: 10.1111/apt.15829.
2
Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply.
Aliment Pharmacol Ther. 2020 Aug;52(3):576-577. doi: 10.1111/apt.15881.
3
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B.信函：慢性乙型肝炎患者血清乙肝病毒DNA与肝细胞癌风险
Aliment Pharmacol Ther. 2021 Mar;53(6):761-762. doi: 10.1111/apt.16264.
4
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.
Aliment Pharmacol Ther. 2016 Jul;44(2):210-1. doi: 10.1111/apt.13674.
5
Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Aliment Pharmacol Ther. 2017 May;45(9):1286-1288. doi: 10.1111/apt.13983.
6
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.信函：乙肝表面血清学清除确实降低肝细胞癌风险——作者回复
Aliment Pharmacol Ther. 2016 Sep;44(6):650-1. doi: 10.1111/apt.13730.
7
Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance.
Aliment Pharmacol Ther. 2017 Nov;46(9):906-908. doi: 10.1111/apt.14272.
8
Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B.乙肝表面抗原定量可预测慢性乙型肝炎患者的抗病毒反应及肝细胞癌的发生。
Korean J Intern Med. 2017 Jul;32(4):631-633. doi: 10.3904/kjim.2017.209. Epub 2017 Jun 30.
9
Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients.社论：乙肝病毒DNA阈值与肝细胞癌风险：HBeAg阳性与HBeAg阴性患者的不同数值模式
Aliment Pharmacol Ther. 2020 Jun;51(12):1439-1440. doi: 10.1111/apt.15783.
10
Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients. Authors' reply.
Aliment Pharmacol Ther. 2020 Jun;51(12):1440-1441. doi: 10.1111/apt.15794.